Iterion Therapeutics

Share on: 
Business Area(s): 

Iterion Therapeutics, previously Beta Cat Pharmaceuticals, is a clinical-stage company developing novel therapies for cancer and other diseases. The Company’s lead product, Tegavivint, is a potent and selective inhibitor of transducin β-like protein 1 (TBL1), a downstream component of the Wnt/beta-catenin signaling pathway.

Houston TX
United States